The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.21BCNY
481.61M · vs all stocks (USD)
Updated Nov 19, 2026
Trailing P/E
33.28x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Revenue (TTM)
2.96BCNY
444.56M · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
3.31%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Beta
0.1100x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-37.42%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
3.21BCNY
481.61M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
2.68BCNY
401.80M · vs all stocks (USD)
Updated Nov 19, 2026
Trailing P/E
33.28x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Forward P/E
15.03x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Price to Sales (TTM)
1.08x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Price to Book (MRQ)
2.45x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Enterprise to Revenue
0.9040x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Enterprise to EBITDA
18.48x
vs Business Equipment & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.46×.Updated Nov 19, 2026
Gross Margin
16.54%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Profit Margin
3.31%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Operating Margin
3.62%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Return on Assets (TTM)
3.00%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Return on Equity (TTM)
7.83%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Revenue (TTM)
2.96BCNY
444.56M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
5.55CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
7.80%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Gross Profit (TTM)
438.36MCNY
65.75M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
162.79MCNY
24.42M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
98.08MCNY
14.71M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-81.80%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Operating Cash Flow (TTM)
248.70MCNY
37.30M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
309.66MCNY
46.45M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
0.51%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
0.00%
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Revenue
2.75BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.28BCNYFY2025 · Dec 31, 2025
Gross Profit
460.66MCNYFY2025 · Dec 31, 2025
Operating Income
161.27MCNY
24.19M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
179.31MCNYFY2025 · Dec 31, 2025
Income Tax Expense
14.75MCNYFY2025 · Dec 31, 2025
Net Income
164.56MCNYFY2025 · Dec 31, 2025
EBIT
186.24MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
240.80MCNYFY2025 · Dec 31, 2025
Research & Development
26.99MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
127.65MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
13.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.27MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.94MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.3100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.3100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
530.83MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
530.83MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
164.56MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
166.46MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-20.99MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
129.11MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
164.56MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
15.15MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
11.88MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-25.12MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-187.45MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.93BCNYFY2025 · Dec 31, 2025
Sale of Investments
3.00BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-56.38MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-169.01MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
792.66MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-761.71MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-522.04KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-58.35MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-27.92MCNYFY2025 · Dec 31, 2025
Shares Outstanding
534.27MSharesUpdated Nov 19, 2026
Float Shares
271.81MSharesUpdated Nov 19, 2026
% Held by Insiders
49.66%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
0.35%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
885.97MCNY
132.89M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
1.66CNYUpdated Nov 19, 2026
Total Debt (MRQ)
327.14MCNY
49.07M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
0.2505x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Current Ratio (MRQ)
1.78x
vs Business Equipment & Supplies peers
Updated Nov 19, 2026
Book Value per Share (MRQ)
2.44CNYUpdated Nov 19, 2026
Total Assets
2.37BCNY
355.18M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.76BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.13BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
609.03MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
14.97MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.12BCNYFY2025 · Dec 31, 2025
Cash
127.50MCNYFY2025 · Dec 31, 2025
Cash Equivalents
48.64MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
176.14MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
398.39MCNYFY2025 · Dec 31, 2025
Accounts Receivable
594.83MCNYFY2025 · Dec 31, 2025
Inventory
198.25MCNYFY2025 · Dec 31, 2025
Accounts Payable
607.97MCNYFY2025 · Dec 31, 2025
Short-term Debt
367.23MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
519.18KCNYFY2025 · Dec 31, 2025
Long-term Debt
14.25MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
534.27MCNYFY2025 · Dec 31, 2025
Retained Earnings
-14.64MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.24BCNY
185.66M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
8.51MCNYFY2025 · Dec 31, 2025
52-Week Low
5.64CNYUpdated Nov 19, 2026
52-Week High
10.65CNYUpdated Nov 19, 2026
52-Week Change
-37.42%
vs all stocks
Updated Nov 19, 2026
Beta
0.1100x
vs all stocks
Updated Nov 19, 2026
50-Day MA
6.62CNYUpdated Nov 19, 2026
200-Day MA
7.28CNYUpdated Nov 19, 2026
Avg 10-Day Volume
9.77MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
18.67MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
0.1800CNYUpdated Nov 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.44: safe zoneNotable
Altman Z-Score: 3.44
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $46.45M, above the global median of $18.58MNotable